Tivicay 50 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9KH3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,723
Award facts
- Contract value 100% obligated
- $44,723.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $44,723.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-tablet bottles of Tivicay 50 mg tablets. This award, issued on January 8, 2026, with an ultimate completion date of January 9, 2026, represents a competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. Tivicay is an antiretroviral medication used in the treatment of HIV infection, reflecting the company's role in supplying critical pharmaceutical commodities to support federal healthcare systems.
This delivery order is executed under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a broad range of medications, vaccines, and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp's consistent competitive success in federal procurement reflects its capability to efficiently fulfill government medical supply requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9KH3?
SPE2DR26F9KH3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F9KH3 worth?
The government has obligated $44,723 on SPE2DR26F9KH3.
Is contract SPE2DR26F9KH3 an order under another contract?
Yes. SPE2DR26F9KH3 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KH3 competed?
The extent of competition for SPE2DR26F9KH3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award